- Drug Pipelines
- September 2022
- 30 Pages
Global
From €3133EUR$3,250USD£2,603GBP
- Drug Pipelines
- September 2022
- 30 Pages
Global
From €3133EUR$3,250USD£2,603GBP
- Report
- September 2022
- 30 Pages
Global
From €3133EUR$3,250USD£2,603GBP
- Report
- September 2022
- 150 Pages
Global
From €3807EUR$3,950USD£3,164GBP
- Report
- September 2022
- 235 Pages
Global
From €7229EUR$7,500USD£6,008GBP
- Report
- August 2022
- 285 Pages
Global
From €9157EUR$9,500USD£7,610GBP
- Report
- August 2022
- 142 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- August 2022
- 151 Pages
Global
From €9157EUR$9,500USD£7,610GBP
- Report
- August 2022
- 75 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- August 2022
- 141 Pages
Global
From €7229EUR$7,500USD£6,008GBP
- Report
- August 2022
- 100 Pages
Global
From €3807EUR$3,950USD£3,164GBP
- Report
- August 2022
- 240 Pages
Global
From €7229EUR$7,500USD£6,008GBP
- Report
- August 2022
- 80 Pages
Global
From €3807EUR$3,950USD£3,164GBP
- Report
- August 2022
- 70 Pages
Global
From €3807EUR$3,950USD£3,164GBP
- Report
- August 2022
- 167 Pages
Global
From €7229EUR$7,500USD£6,008GBP
- Report
- August 2022
- 85 Pages
Global
From €3807EUR$3,950USD£3,164GBP
- Clinical Trials
- August 2022
- 150 Pages
Global
From €2410EUR$2,500USD£2,003GBP
- Report
- July 2022
- 100 Pages
Global
From €2651EUR$2,750USD£2,203GBP
- Report
- July 2022
- 100 Pages
Global
From €2651EUR$2,750USD£2,203GBP
- Report
- July 2022
- 252 Pages
Global
From €7229EUR$7,500USD£6,008GBP
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more